Select your specialty for customized content
The Ever-Expanding Potential
of Precision Medicine
Supporting pathologists and the broader oncology care team in removing barriers to clinically actionable biomarker testing.
Explore Biomarker Testing Guidelines
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) inform biomarker testing.
Access quick-reference flow charts of National Comprehensive Cancer Network® (NCCN®) biomarker testing recommendations by tumor type:
NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.Â
aThis page contains content pertaining to non-small cell lung cancer (NSCLC) only.
NCCN, National Comprehensive Cancer Network.
The Biomarkers Informing Treatment Options
Many tumors contain actionable biomarkers . Testing unlocks this critical information, helping patients receive the right treatment for their unique cancer.
Select a biomarker below to view available diagnostic prevalence as well as practical information on how to test for them:
AKT1, serine/threonine protein kinase 1; BRCA1/2, BReast CAncer susceptibility gene 1/2; EGFR, epidermal growth factor receptor; ERBB2, erb-b2 receptor tyrosine kinase 2; HER2, human epidermal growth factor receptor 2; HRD, homologous recombination deficiency; HRRm, homologous recombination repair gene mutation; PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; PTEN, phosphatase and tensin homolog.
How Pathologists Can Help Optimize Precision Medicine
Improve your MDT's biomarker testing approach with reflexive testing, synoptic reporting, and enhanced communication.
Collaborate to improve access to
targeted treatment
Keep up with the pace of precision medicine
MDT, multidisciplinary team.
Solutions for Common Biomarker Testing Challenges
Find new ways to optimize your testing protocols and address common testing challenges to help ensure that all eligible patients can benefit from the potential of biomarker-based therapies.
Helpful Resources
Check out these featured resources, designed to help support pathologists in precision medicine and biomarker testing. Â
Add your preferred resources to My Favorites—a personalized list of resources to download and share with your peers or patients.
FOR HCPS
Controlling preanalytical variables in blood specimens to help ensure quality biomarker testing resultsDownload this resource to understand the College of American Pathologists’ (CAP) recommendations for controlling preanalytic variables in blood specimens for reliable biomarker testing results.
FOR HCPS
Controlling preanalytical variables in tissue specimen variables to help ensure quality biomarker testing resultsDownload this resource to understand the College of American Pathologists’ (CAP) recommendations for controlling preanalytic variables in tissue specimens for reliable biomarker testing results.
If you have questions related to precision medicine, browse our FAQs to find quick answers.
Subscribe to Emails
Subscribe and stay up to date with information and insights on precision medicine.
Subscribe
Connect With Us
Connect with our Precision Medicine Team for support on biomarker testing relevant to pathologists.
Connect with us